Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...

Weight loss drugs, compounding, vitamin D, and AI all piqued readers’ interest — and sometimes, ire — this past year.

Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, said Monday it was ...

STOCKHOLM (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense ...

Dow, S&P 500, and Nasdaq futures are all rising in premarket trading Monday as the stock market braces itself for the Fed's rate decision this week.

Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, said Monday it was ...

Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a completely new production facility in Odense, ...

Danish healthcare firm Novo Nordisk announced plans on Monday for new investment in a production facility in one of the ...

Healthcare company Novo Nordisk A/S (NVO) announced Monday that it plans to invest 8.5 billion Danish kroner to establish a ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

The pharmaceutical company will establish a production facility in Odense to accommodate multiple product types within the ...